Terug
27
Dagbereik
€ 73,82
€ 75,77
52-Weeksbereik
€ 47,25
€ 108,91
Volume
1.330.810
50D / 200D Gem.
€ 71,57
/
€ 65,11
Vorige Slotkoers
€ 75,73
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 21,1 | 0,3 |
| P/B | 4,5 | 2,9 |
| ROE % | 21,5 | 3,7 |
| Net Margin % | 15,2 | 3,8 |
| Rev Growth 5Y % | 38,0 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 87,00
+17.2%
Low: € 72,00
High: € 110,00
Forward K/W
14,6
Forward WPA
€ 5,19
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,5 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 8,44
€ 7,97 – € 9,60
|
2,2 B | 1 |
| FY2029 |
€ 7,62
€ 7,20 – € 8,67
|
2 B | 1 |
| FY2028 |
€ 7,63
€ 5,63 – € 10,41
|
1,9 B | 3 |
Belangrijkste Punten
Revenue grew 37,99% annually over 5 years — strong growth
Earnings declined -25,25% over the past year
ROE of 21,45% indicates high profitability
Net margin of 15,15% shows strong profitability
Debt/Equity of 0,00 — conservative balance sheet
Generating 354,05M in free cash flow
Groei
Revenue Growth (5Y)
37,99%
Revenue (1Y)0,50%
Earnings (1Y)-25,25%
FCF Growth (3Y)16,99%
Kwaliteit
Return on Equity
21,45%
ROIC21,38%
Net Margin15,15%
Op. Margin20,16%
Veiligheid
Debt / Equity
0,00
Current Ratio2,70
Interest Coverage15,74
Waardering
P/E Ratio
21,08
P/B Ratio4,52
EV/EBITDA14,69
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,50% | Revenue Growth (3Y) | 9,05% |
| Earnings Growth (1Y) | -25,25% | Earnings Growth (3Y) | -15,44% |
| Revenue Growth (5Y) | 37,99% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,54B | Net Income (TTM) | 233,56M |
| ROE | 21,45% | ROA | 10,49% |
| Gross Margin | 61,10% | Operating Margin | 20,16% |
| Net Margin | 15,15% | Free Cash Flow (TTM) | 354,05M |
| ROIC | 21,38% | FCF Growth (3Y) | 16,99% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 2,70 |
| Interest Coverage | 15,74 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 21,08 | P/B Ratio | 4,52 |
| P/S Ratio | 3,19 | PEG Ratio | -0,82 |
| EV/EBITDA | 14,69 | Dividend Yield | 0,00% |
| Market Cap | 4,92B | Enterprise Value | 4,56B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,54B | 1,53B | 1,30B | 935,06M | 425,21M |
| Net Income | 233,56M | 312,44M | 326,66M | 28,07M | -71,28M |
| EPS (Diluted) | 3,41 | 4,36 | 4,65 | 0,40 | -1,06 |
| Gross Profit | 941,95M | 988,29M | 709,54M | 581,70M | 187,70M |
| Operating Income | 310,83M | 456,98M | 364,64M | 36,20M | -60,83M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,23B | 1,98B | 1,65B | 1,32B | 863,78M |
| Total Liabilities | 1,14B | 892,33M | 835,26M | 874,11M | 399,35M |
| Shareholders' Equity | 1,09B | 1,09B | 815,89M | 447,15M | 464,44M |
| Total Debt | 738.000,0 | 619,44M | 616,95M | 583,51M | 191,31M |
| Cash & Equivalents | 359,12M | 912,81M | 713,66M | 415,65M | 98,51M |
| Current Assets | 899,96M | 1,33B | 1,09B | 677,62M | 235,79M |
| Current Liabilities | 333,42M | 240,53M | 187,35M | 247,70M | 90,50M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#178 of 203
Recente Activiteit
Ingestapt
Value Investing (Warren Buffett)
Mar 24, 2026